Medpace (MEDP) stock closed down 1.52%, but expected to show growth in earnings and revenue

From Nasdaq: 2024-09-03 18:15:08

Medpace (MEDP) closed at $349.87, down 1.52% from the previous day, outperforming S&P 500’s 2.12% loss. In the last month, the stock dropped 5.76%, underperforming the Medical sector’s 5.45% gain. Analysts project an EPS of $2.78 and revenue of $540.49 million, with a Zacks Rank of #3 (Hold).

Ahead of its earnings disclosure, Medpace is expected to show a 25.23% increase in EPS and a 9.74% revenue growth compared to the previous year. Zacks Consensus Estimates predict full-year earnings of $11.66 per share and revenue of $2.13 billion, with a premium Forward P/E ratio of 30.48.



Read more at Nasdaq: Medpace (MEDP) Stock Moves -1.52%: What You Should Know